PRIA, Government Policy, Made Personal

Summary

The United States will fund and coordinate several joint programs with Israel in health, energy, transport, space, and water research. Up to $4,000,000 is authorized for 2021–2023 for a U.S.-Israel program to develop health technologies (like drugs, vaccines, ventilators, tests, and telemedicine) with a focus on COVID-19 and personalized medicine. Israel must match those funds. Money can support an existing program or a new one set up under the 2008 science-and-technology agreement. Any grant-funded research must have its publications and results posted on the Department of Health and Human Services website. The President may name a State Department official to coordinate U.S.-Israel research and development with the Israel Innovation Authority. The FDA is asked to study opening an office in Israel and must report within one year after January 1, 2021 to the relevant Senate and House committees on the benefits. The Department of Energy may get $4,000,000 for 2021 for the U.S.-Israel Energy Center, and Congress recommends at least $2,000,000 yearly for certain Israel-related energy grants. Other items require an annual DOT- Israel transport dialogue, continued NASA cooperation on peaceful space projects with protections for sensitive information, a one-year OSTP report on desalination R&D cooperation, and VA exploration of PTSD research ties with Israeli experts.

Title 22, §8607

Foreign Relations and Intercourse, Source: USLM XML via OLRC

(a)In general

Activities authorized under this section shall be carried out with the concurrence of the Secretary of State and aligned with the National Security Strategy of the United States, the United States Government Global Health Security Strategy, the Department of State Integrated Country Strategies, the USAID Country Development Cooperation Strategies, and any equivalent or successor plans or strategies, as necessary and appropriate.

(b)Development of health technologies

(1)In general

There is authorized to be appropriated to the Secretary of Health and Human Services $4,000,000 for fiscal years 2021 through 2023 for a bilateral cooperative program with the Government of Israel that awards grants for the development of health technologies, which may include health technologies listed in paragraph (2), subject to paragraph (3), with an emphasis on collaboratively advancing the use of technology and personalized medicine in relation to COVID–19.

(2)Types of health technologies

The health technologies described in this paragraph are technologies such as, drugs and vaccines, ventilators, diagnostic tests, and technologies to facilitate telemedicine.

(3)Restrictions on funding

Amounts appropriated pursuant to paragraph (1) are subject to a matching contribution from the Government of Israel.

(4)Option for establishing new program

Amounts appropriated pursuant to paragraph (1) may be expended for a bilateral program with the Government of Israel that—

(A)is in existence on the day before January 1, 2021, for the purposes described in paragraph (1); or

(B)is established after January 1, 2021, by the Secretary of Health and Human Services, in consultation with the Secretary of State, in accordance with the Agreement between the Government of the United States of America and the Government of the State of Israel on Cooperation in Science and Technology for Homeland Security Matters, done at Jerusalem May 29, 2008 (or a successor agreement), for the purposes described in paragraph (1).

(5)Public availability

The Secretary shall require, as a condition of any grant awarded under this subsection, that all research publications and results of such research, including basic and applied research, shall be made publicly available on the website of the Department of Health and Human Services.

(c)Coordinator of United States-Israel Research and Development

(1)In general

The President may designate the Assistant Secretary of State for the Bureau of Oceans and International Environmental and Scientific Affairs, or another appropriate Department of State official, to act as Coordinator of United States-Israel Research and Development (referred to in this subsection as the “Coordinator”).

(2)Authorities and duties

The Coordinator, in conjunction with the heads of relevant Federal Government departments and agencies and in coordination with the Israel Innovation Authority, may oversee civilian science and technology programs on a joint basis with Israel.

(d)Office of Global Policy and Strategy of the Food and Drug Administration

(1)In general

It is the sense of Congress that the Commissioner of the Food and Drug Administration should seek to explore collaboration with Israel through the Office of Global Policy and Strategy.

(2)Report

Not later than one year after January 1, 2021, the Commissioner, acting through the head of the Office of Global Policy and Strategy, shall submit a report describing the benefits to the United States and to Israel of opening an office in Israel for the Office of Global Policy and Strategy to—

(A)the Committee on Foreign Relations of the Senate;

(B)the Committee on Health, Education, Labor, and Pensions of the Senate;

(C)the Committee on Foreign Affairs of the House of Representatives; and

(D)the Committee on Energy and Commerce of the House of Representatives.

(e)United States-Israel Energy Center

There is authorized to be appropriated to the Secretary of Energy $4,000,000 for fiscal year 2021 to carry out the activities of the United States-Israel Energy Center established pursuant to section 17337(d) of title 42.

(f)United States-Israel Binational Industrial Research and Development Foundation

It is the sense of Congress that grants to promote covered energy projects conducted by, or in conjunction with, the United States-Israel Binational Industrial Research and Development Foundation should be funded at not less than $2,000,000 annually under section 17337(b) of title 42.

(g)Omitted

(h)Annual policy dialogue

It is the sense of Congress that the Department of Transportation and Israel’s Ministry of Transportation should engage in an annual policy dialogue to implement the 2016 Memorandum of Cooperation signed by the Secretary of Transportation and the Israeli Minister of Transportation.

(i)Cooperation on space exploration and science initiatives

The Administrator of the National Aeronautics and Space Administration shall continue to work with the Israel Space Agency to identify and cooperatively pursue peaceful space exploration and science initiatives in areas of mutual interest, taking all appropriate measures to protect sensitive information, intellectual property, trade secrets, and economic interests of the United States.

(j)Research and development cooperation relating to desalination technology

Not later than one year after January 1, 2021, the Director of the Office of Science and Technology Policy shall submit a report that describes research and development cooperation with international partners, such as the State of Israel, in the area of desalination technology in accordance with section 9(b)(3) of the Water Desalination Act of 1996 (42 U.S.C. 10301 note) to—

(1)the Committee on Foreign Relations of the Senate;

(2)the Committee on Energy and Natural Resources of the Senate;

(3)the Committee on Foreign Affairs of the House of Representatives; and

(4)the Committee on Natural Resources of the House of Representatives.

(k)Research and treatment of posttraumatic stress disorder

It is the sense of Congress that the Secretary of Veterans Affairs should seek to explore collaboration between the Mental Illness Research, Education and Clinical Centers of Excellence and Israeli institutions with expertise in researching and treating posttraumatic stress disorder.

Notes & Related Subsidiaries

Editorial Notes

References in Text

section 9(b)(3) of the Water Desalination Act of 1996, referred to in subsec. (j), is section 9(b)(3) of Pub. L. 104–298, which is set out in a note under section 10301 of Title 42, The Public Health and Welfare. Codification Section is comprised of section 1280A of Pub. L. 116–283. Subsec. (g) of section 1280A of Pub. L. 116–283 amended section 8606 of this title. Section was enacted as part of the United States-Israel Security Assistance Authorization Act of 2020 and also as part of the William M. (Mac) Thornberry National Defense Authorization Act for Fiscal Year 2021, and not as part of the United States-Israel Enhanced Security Cooperation Act of 2012 which comprises this chapter.

§8607 Other Matters of Cooperation

Summary

Title 22, §8607

Notes & Related Subsidiaries

Editorial Notes

References in Text

Citations & Metadata